Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice
- 1 January 2011
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 146 (2) , 270-272
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Ethics in the authorship and publishing of scientific articlesInternational Journal of Cardiology, 2010
- Antibody‐directed myostatin inhibition in 21‐mo‐old mice reveals novel roles for myostatin signaling in skeletal muscle structure and functionThe FASEB Journal, 2010
- Making Fast-Twitch Dystrophic Muscles Bigger Protects Them from Contraction Injury and Attenuates the Dystrophic PathologyThe American Journal of Pathology, 2010
- Ethical authorship and publishingInternational Journal of Cardiology, 2009
- Chronic β2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The PPARα‐PGC‐1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased MyocardiumPPAR Research, 2007
- NOS isoform‐specific regulation of basal but not exercise‐induced mitochondrial biogenesis in mouse skeletal muscleThe Journal of Physiology, 2007
- Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during β-adrenergic catecholamine induced cardiotoxicity in ratsChemico-Biological Interactions, 2006
- Protecting the myocardium: A role for the β2 adrenergic receptor in the heartCritical Care Medicine, 2004
- Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002